Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (171-180 of 369) with videos related to

Pageof 37
Sort By:
The Journal of Infectious Diseases|July 24, 2014
Transmission of tuberculosis in a South African community with a high prevalence of HIV infectionKeren Middelkoop, Barun Mathema, Landon Myer, et al.
Plos One|March 20, 2012
Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South AfricaJulie H Levison, Catherine Orrell, Sébastien Gallien, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 8, 2009
HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policiesMichael D April, Rochelle P Walensky, Yuchiao Chang, et al.
The Pediatric Infectious Disease Journal|March 7, 2024
Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial RecordsPatience Nyakato, Andrew Boulle, Robin Wood, et al.
Journal of the International AIDS Society|January 28, 2012
The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South AfricaQuazi Ataher, Simon Portsmouth, Laura A Napolitano, et al.
Journal of the International AIDS Society|October 5, 2011
Treatment as prevention: preparing the wayBrian Williams, Robin Wood, Victor Dukay, et al.
AIDS (London, England)|July 9, 2004
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patientsJoseph C Gathe, Prudence Ive, Robin Wood, et al.
Plos Medicine|December 2, 2005
Cost-effectiveness of highly active antiretroviral therapy in South AfricaMotasim Badri, Gary Maartens, Sundhiya Mandalia, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2015
The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescentsJason R Andrews, Mark Hatherill, Hassan Mahomed, et al.
AIDS (London, England)|March 7, 2013
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling studyJanne Estill, Matthias Egger, Nello Blaser, et al.
Pageof 37

Showing results (171-180 of 369) with videos related to

Sort By:
Pageof 37
The Journal of Infectious Diseases|July 24, 2014
Transmission of tuberculosis in a South African community with a high prevalence of HIV infectionKeren Middelkoop, Barun Mathema, Landon Myer, et al.
Plos One|March 20, 2012
Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South AfricaJulie H Levison, Catherine Orrell, Sébastien Gallien, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 8, 2009
HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policiesMichael D April, Rochelle P Walensky, Yuchiao Chang, et al.
The Pediatric Infectious Disease Journal|March 7, 2024
Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial RecordsPatience Nyakato, Andrew Boulle, Robin Wood, et al.
Journal of the International AIDS Society|January 28, 2012
The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South AfricaQuazi Ataher, Simon Portsmouth, Laura A Napolitano, et al.
Journal of the International AIDS Society|October 5, 2011
Treatment as prevention: preparing the wayBrian Williams, Robin Wood, Victor Dukay, et al.
AIDS (London, England)|July 9, 2004
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patientsJoseph C Gathe, Prudence Ive, Robin Wood, et al.
Plos Medicine|December 2, 2005
Cost-effectiveness of highly active antiretroviral therapy in South AfricaMotasim Badri, Gary Maartens, Sundhiya Mandalia, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2015
The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescentsJason R Andrews, Mark Hatherill, Hassan Mahomed, et al.
AIDS (London, England)|March 7, 2013
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling studyJanne Estill, Matthias Egger, Nello Blaser, et al.
Pageof 37